Mounjaro®
Starting from £179.99/mo
Start journey Learn moreHeadaches are one of the more commonly reported side effects of Mounjaro (tirzepatide), particularly in the first few weeks of treatment or after a dose increase. They are usually mild, tend to settle as your body adjusts, and are rarely a reason to stop treatment. That said, a headache that is severe, persistent or feels different from your usual ones deserves prompt attention. Mounjaro is a prescription-only medicine; a GPhC-registered prescriber assesses your suitability before any treatment begins, and side-effect management is part of that clinical relationship throughout.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide slows the rate at which food leaves the stomach and reduces appetite through its dual action on GIP and GLP-1 receptors. Both of these effects are clinically useful for weight management, but they also change your normal eating and drinking patterns fairly abruptly. Many people eat noticeably less in the first days after a new dose, drink less fluid without realising it, and may experience nausea that further discourages them from keeping on top of hydration. Mild dehydration is a well-established trigger for tension-type headaches, so the connection is straightforward even if it feels frustrating.
There is also a calorie-reduction component. A sudden drop in carbohydrate intake, which often accompanies the appetite suppression, can cause blood-glucose fluctuations that some people feel as a dull headache, fatigue or light-headedness. The NHS patient information for tirzepatide lists headache among the common side effects, reflecting how frequently it appears in the clinical trial data.
The timing matters too. Headaches tend to cluster in the first one to two weeks after starting treatment or moving to a higher dose. If yours arrived shortly after your most recent pen, that pattern fits, and our dedicated page on Mounjaro headache explains why this timing is so common and what it means for your treatment. Our prescribers at the wider Mounjaro side effects page cover the full spectrum of what to expect across the titration schedule.
The most reliable starting point is water. Aim for roughly two litres across the day, spread out rather than drunk all at once, which can itself provoke nausea. If plain water is unappealing, diluted squash or a low-sugar electrolyte drink can make it easier to keep sipping. Setting a reminder on your phone before the school run is a small practical move that some people find genuinely useful, it is easy to reach mid-morning having had almost nothing.
Paracetamol is generally considered compatible with Mounjaro at standard doses, but check with your prescriber or pharmacist before taking any painkiller if you are unsure, particularly if you are managing other conditions. Ibuprofen and similar anti-inflammatories are worth querying separately; they are not universally appropriate for everyone on weight-management treatment.
Eating small, regular, protein-containing meals reduces the blood-sugar swings that can contribute to head pain. Rest and avoiding bright screens help in the same ways they would for any tension headache. If nausea is making it harder to eat or drink, the guidance on managing Mounjaro nausea runs through approaches that can break the cycle.
Headaches that ease with hydration and rest are reassuring. Ones that do not respond, or that recur reliably on the same day each week after your injection, are worth mentioning to your prescriber at your next review, and you can find more practical detail on what to do when you get a headache from Mounjaro if you want to work through your options before that conversation.
Most headaches on Mounjaro are a nuisance, not a warning. A small number are not. Contact a GP, call 111, or go to A&E if your headache is:
Sudden and severe, sometimes described as a "thunderclap" or the worst headache of your life; this requires emergency attention regardless of whether you are on any medication. Accompanied by visual disturbance, confusion, weakness on one side, or difficulty speaking. Persistent for more than a few days without improvement. Occurring alongside severe abdominal pain that spreads toward the back, this combination can indicate acute pancreatitis, which the MHRA highlighted as a known but infrequent serious risk in its January 2026 Drug Safety Update for GLP-1 medicines. Any new headache pattern that feels distinctly different from your normal experience.
You can also report any suspected side effect, however minor, through the MHRA Yellow Card scheme. Reports from patients matter; they contribute to the post-market safety monitoring that catches signals the clinical trials did not.
Rarely, and not without speaking to a prescriber first. Stopping abruptly means missing out on the clinical benefit for no gain; in most cases, the headache resolves on its own as your body settles into the new dose. What is useful is flagging the symptom through your aftercare channel so your prescriber can advise whether to stay at the current dose longer, adjust anything in your routine, or investigate further.
Headaches that are clearly dose-related (appearing predictably after each injection and fading within a day or two) often improve as titration slows or stabilises. That is different from a headache that is worsening, changing character, or coming with other symptoms.
If you are weighing up whether Mounjaro is right for you alongside questions like this, including whether your medical history affects your suitability, our page on taking Mounjaro after gallbladder removal is one example of the condition-specific guidance available. The Mounjaro overview covers the full clinical picture, and our clinical team's approach to patient care is outlined on the clinical team profile. You can also explore treatment options more broadly if you want to understand what a consultation covers before you start. Side-effect concerns are discussed as a normal part of that process, there are no right or wrong questions to ask.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.